Cargando…

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease

BACKGROUND: The correlation of low serum albumin with mortality in patients with chronic kidney disease (CKD) is partly linked to its association with systemic inflammation. However, it is not clear to what extent albumin's correlation with mortality depends on concomitant systemic inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alves, Filipa Caeiro, Sun, Jia, Qureshi, Abdul Rashid, Dai, Lu, Snaedal, Sunna, Bárány, Peter, Heimbürger, Olof, Lindholm, Bengt, Stenvinkel, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752034/ https://www.ncbi.nlm.nih.gov/pubmed/29298330 http://dx.doi.org/10.1371/journal.pone.0190410

Ejemplares similares

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
por: Sjöberg, Bodil, et al.
Publicado: (2014)

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
por: Li, Xiejia, et al.
Publicado: (2023)

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019)

High-sensitivity troponins in dialysis patients: variation and prognostic value
por: Snaedal, Sunna, et al.
Publicado: (2020)

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
por: Dai, Lu, et al.
Publicado: (2017)

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
por: Mukai, Hideyuki, et al.
Publicado: (2018)

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
por: Danielson, Kristin, et al.
Publicado: (2014)

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
por: Pei, Ming, et al.
Publicado: (2019)

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
por: Missailidis, Catharina, et al.
Publicado: (2016)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
por: Molanaei, Hadi, et al.
Publicado: (2018)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
por: Machowska, Anna, et al.
Publicado: (2016)

Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
por: Ryu, Kakei, et al.
Publicado: (2023)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method
por: Bobrowski, Leon, et al.
Publicado: (2014)

Aortic Valve Calcium Associates with All-Cause Mortality Independent of Coronary Artery Calcium and Inflammation in Patients with End-Stage Renal Disease
por: Dai, Lu, et al.
Publicado: (2020)

A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients
por: Nilsson, Erik, et al.
Publicado: (2016)

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
por: Dai, Lu, et al.
Publicado: (2019)

Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
por: Dai, Lu, et al.
Publicado: (2021)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
por: Meuwese, Christiaan Lucas, et al.
Publicado: (2015)

Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
por: Witasp, Anna, et al.
Publicado: (2022)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
por: Runesson, Björn, et al.
Publicado: (2019)

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
por: Hernandez, Leah, et al.
Publicado: (2022)

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
por: Sjöberg, B., et al.
Publicado: (2015)

Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
por: Arefin, Samsul, et al.
Publicado: (2022)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
por: Dai, Lu, et al.
Publicado: (2020)

Incidence of Fractures Before and After Dialysis Initiation
por: Iseri, Ken, et al.
Publicado: (2020)

Role of Uremic Toxins in Early Vascular Ageing and Calcification
por: Kyriakidis, Nikolaos C., et al.
Publicado: (2021)

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
por: Runesson, Björn, et al.
Publicado: (2019)

Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study
por: Al-Sodany, Ehab, et al.
Publicado: (2022)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes
por: Samal, Shailesh Kumar, et al.
Publicado: (2020)

Ultraprocessed foods and chronic kidney disease—double trouble
por: Avesani, Carla Maria, et al.
Publicado: (2023)

Albumin for End-Stage Liver Disease
por: Lee, June Sung
Publicado: (2012)

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016)

Educating end-stage renal disease patients on dialysis modality selection
por: Covic, Adrian, et al.
Publicado: (2010)

Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy
por: Luttropp, Karin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vm7mf1cmcadksifnlgi7ev9aqp